136 related articles for article (PubMed ID: 14688807)
1. Polymorphisms of the angiotensinogen gene and the outcome of microalbuminuria in essential hypertension: a 3-year follow-up study.
Marin P; Julve R; Chaves FJ; Giner V; Pascual JM; Armengod ME; Redon J
J Hum Hypertens; 2004 Jan; 18(1):25-31. PubMed ID: 14688807
[TBL] [Abstract][Full Text] [Related]
2. Body weight changes and the A-6G polymorphism of the angiotensinogen gene.
Chaves FJ; Giner V; Corella D; Pascual J; Marin P; Armengod ME; Redon J
Int J Obes Relat Metab Disord; 2002 Sep; 26(9):1173-8. PubMed ID: 12187393
[TBL] [Abstract][Full Text] [Related]
3. Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study.
Pascual JM; Rodilla E; Miralles A; Gonzalez C; Redon J
J Hypertens; 2006 Nov; 24(11):2277-84. PubMed ID: 17053551
[TBL] [Abstract][Full Text] [Related]
4. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[TBL] [Abstract][Full Text] [Related]
6. T1198C polymorphism of the angiotensinogen gene and antihypertensive response to angiotensin-converting enzyme inhibitors.
Yu H; Lin S; Liu G; Zhang Y; Deng C; Ma W
Hypertens Res; 2005 Dec; 28(12):981-6. PubMed ID: 16671337
[TBL] [Abstract][Full Text] [Related]
7. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
[TBL] [Abstract][Full Text] [Related]
8. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
[TBL] [Abstract][Full Text] [Related]
9. [Insertion/deletion polymorphism of the gene encoding for angiotensin-converting enzyme and microalbuminuria in essential arterial hypertension].
Rovira E; Chaves FJ; Julve R; Pascual JM; Miralles A; Armengod ME; Redon J
Med Clin (Barc); 1999 May; 112(19):726-30. PubMed ID: 10394569
[TBL] [Abstract][Full Text] [Related]
10. Influence of the I/D polymorphism of the angiotensin-converting enzyme gene on the outcome of microalbuminuria in essential hypertension.
Redon J; Chaves FJ; Liao Y; Pascual JM; Rovira E; Armengod ME; Cooper RS
Hypertension; 2000 Jan; 35(1 Pt 2):490-5. PubMed ID: 10642347
[TBL] [Abstract][Full Text] [Related]
11. [The relationship between the variants in 5' upstream core promoter A(-6)G and A(-20)C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang].
Li NF; Zhou L; Wu WD; Shi Y; Wang XL; Wang J; Li HJ; Zhang DL; Zu H; Ouyang WJ; Bu KL; Zhou KM; Cheng QY; Guli N; Zhu DH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):23-8. PubMed ID: 14767903
[TBL] [Abstract][Full Text] [Related]
12. Factors related to the occurrence of microalbuminuria during antihypertensive treatment in essential hypertension.
Redon J; Rovira E; Miralles A; Julve R; Pascual JM
Hypertension; 2002 Mar; 39(3):794-8. PubMed ID: 11897766
[TBL] [Abstract][Full Text] [Related]
13. [The AGT genotype affects the antihypertensive effects of benazepril].
Yu HM; Lin SG; Zhang YQ; Ma WJ; Liu GZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep; 33(9):819-23. PubMed ID: 16266458
[TBL] [Abstract][Full Text] [Related]
14. [Factors associated with changes in microalbuminuria during antihypertensive treatment].
Rovira E; Julve R; Pascual JM; Miralles A; Redon J
Med Clin (Barc); 2000 May; 114(19):721-5. PubMed ID: 10919124
[TBL] [Abstract][Full Text] [Related]
15. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
[TBL] [Abstract][Full Text] [Related]
16. Drug-gene interaction between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and antihypertensive therapy.
Schelleman H; Klungel OH; van Duijn CM; Witteman JC; Hofman A; de Boer A; Stricker BH
Ann Pharmacother; 2006 Feb; 40(2):212-8. PubMed ID: 16449550
[TBL] [Abstract][Full Text] [Related]
17. [Stress-associated hypertension in the work place: results of the STARLET project].
Lüders S; Hammersen F; Kulschewski A; Frerichs A; Frieg R; Hahnheiser D; Reich G; Schnieders M; Schrandt G; Schrader J
Dtsch Med Wochenschr; 2006 Nov; 131(46):2580-5. PubMed ID: 17096303
[TBL] [Abstract][Full Text] [Related]
18. A study of the relationships between angiotensin- converting enzyme gene, chymase gene polymorphisms, pharmacological treatment with ACE inhibitor and regression of left ventricular hypertrophy in essential hypertension patients treated with benazepril.
He H; Li LM; Cao WH; Sun NL; Liu MZ; Hu YH
Ann Hum Biol; 2005; 32(1):30-43. PubMed ID: 15788353
[TBL] [Abstract][Full Text] [Related]
19. Microalbuminuria in essential hypertensives in treatment for hypertension.
Cruz HM; Cruzera AB; Cruz J
Rev Hosp Clin Fac Med Sao Paulo; 1997; 52(5):258-62. PubMed ID: 9595780
[TBL] [Abstract][Full Text] [Related]
20. Gene polymorphisms of the renin-angiotensin system and age-related changes in systolic and diastolic blood pressure in subjects with hypertension.
Rudnichi A; Safar ME; Lajemi M; Benetos A
Am J Hypertens; 2004 Apr; 17(4):321-7. PubMed ID: 15062885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
